Edited by Manuel Corpas, Mahsa Shabani, Jared Roach and Dov Greenbaum.
Volume 15 Supplement 3
Publication of this supplement has not been supported by sponsorship. Information about the source of funding for publication charges can be found in the individual articles. The articles have undergone the journal's standard peer review process for supplements. The Supplement Editors were not involved in the peer review of any articles they co-authored. No other competing interests were declared.
Virtual28-30 April 2021
Personalized medicine is an emerging field, aiming to improve the safety and efficacy of pharmacotherapy. The field’s implementation in clinical care is steadily increasing. Pharmacogenomics are one example of...
Polygenic risk scores (PRS) have been widely applied in research studies, showing how population groups can be stratified into risk categories for many common conditions. As healthcare systems consider applyin...
Understanding public attitudes to genomic data sharing is widely seen as key in shaping effective governance. However, empirical research in this area often fails to capture the contextual nuances of diverse s...
Citation Impact
Journal Impact Factor: 2.0 (2024)
5-year Journal Impact Factor: 2.4 (2024)
Source Normalized Impact per Paper (SNIP): 0.627 (2024)
SCImago Journal Rank (SJR): 0.701 (2024)
Speed
Submission to first editorial decision (median days): 7
Submission to acceptance (median days): 152
Usage 2024
Downloads: 1,862,630
Altmetric mentions: 2
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication